Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

Share Price is delayed by 15 minutes
Get Live Data
279.00    0.50 (0.18%)
Bid:
278.50
Ask:
279.00
Spread: 0.50 (0.18%)
Market Cap: £606.50m
AMS Live PriceLast checked at - London Stock Exchange

Intraday Advanced Medical Solutions Group Share Chart

Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

15 May 2026 13:09

RNS Number : 5747E
Barclays PLC
15 May 2026
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ADVANCED MEDICAL SOLUTIONS GROUP PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

14 May 2026

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

5p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

809,677

0.37%

1,381,001

0.63%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

1,330,553

0.60%

809,308

0.37%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

2,140,230

0.97%

2,190,309

1.00%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

5p ordinary

Purchase

357,317

2.5600 GBP

5p ordinary

Purchase

108,890

2.4990 GBP

5p ordinary

Purchase

39,883

2.5042 GBP

5p ordinary

Purchase

31,360

2.5323 GBP

5p ordinary

Purchase

30,446

2.5043 GBP

5p ordinary

Purchase

26,044

2.5054 GBP

5p ordinary

Purchase

10,920

2.4919 GBP

5p ordinary

Purchase

8,789

2.4927 GBP

5p ordinary

Purchase

5,846

2.4952 GBP

5p ordinary

Purchase

5,498

2.5017 GBP

5p ordinary

Purchase

3,698

2.4839 GBP

5p ordinary

Purchase

2,905

2.4928 GBP

5p ordinary

Purchase

2,800

2.5511 GBP

5p ordinary

Purchase

822

2.4850 GBP

5p ordinary

Purchase

164

2.4863 GBP

5p ordinary

Sale

138,326

2.5600 GBP

5p ordinary

Sale

32,737

2.5218 GBP

5p ordinary

Sale

13,458

2.4900 GBP

5p ordinary

Sale

9,348

2.5212 GBP

5p ordinary

Sale

8,623

2.4922 GBP

5p ordinary

Sale

4,406

2.5542 GBP

5p ordinary

Sale

1,417

2.5135 GBP

5p ordinary

Sale

822

2.4860 GBP

5p ordinary

Sale

269

2.5017 GBP

5p ordinary

Sale

89

2.4865 GBP

5p ordinary

Sale

61

2.4999 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

5p ordinary

SWAP

Increasing Long

8,623

2.4920 GBP

5p ordinary

SWAP

Increasing Long

10,447

2.4454 GBP

5p ordinary

SWAP

Increasing Long

300

2.4849 GBP

5p ordinary

SWAP

Increasing Long

89

2.4865 GBP

5p ordinary

SWAP

Increasing Long

11,208

2.4900 GBP

5p ordinary

SWAP

Increasing Long

61

2.4999 GBP

5p ordinary

SWAP

Increasing Long

269

2.5017 GBP

5p ordinary

SWAP

Increasing Long

1,417

2.5135 GBP

5p ordinary

SWAP

Increasing Long

32,577

2.5216 GBP

5p ordinary

SWAP

Increasing Long

4,406

2.5542 GBP

5p ordinary

SWAP

Increasing Long

160

2.5597 GBP

5p ordinary

SWAP

Increasing Long

9,185

2.5598 GBP

5p ordinary

SWAP

Increasing Long

85,084

2.5600 GBP

5p ordinary

SWAP

Decreasing Long

10,447

2.4454 GBP

5p ordinary

SWAP

Decreasing Long

6,537

2.4937 GBP

5p ordinary

SWAP

Decreasing Long

102,353

2.4994 GBP

5p ordinary

SWAP

Decreasing Long

22,699

2.5013 GBP

5p ordinary

SWAP

Decreasing Long

5,498

2.5017 GBP

5p ordinary

SWAP

Decreasing Long

30,446

2.5043 GBP

5p ordinary

SWAP

Decreasing Long

26,044

2.5054 GBP

5p ordinary

SWAP

Decreasing Long

38,373

2.5064 GBP

5p ordinary

SWAP

Decreasing Long

10,717

2.5165 GBP

5p ordinary

SWAP

Decreasing Long

200,159

2.5600 GBP

5p ordinary

CFD

Increasing Long

5,715

2.5003 GBP

5p ordinary

CFD

Increasing Long

22,794

2.5600 GBP

5p ordinary

CFD

Decreasing Long

6,467

2.4945 GBP

5p ordinary

CFD

Decreasing Long

155,348

2.5600 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

15 May 2026

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETGZGMKZKMGVZM
Date   Source Headline
9th Jul 20263:21 pmRNSForm 8.5 (EPT/NON-RI) -Amend Advanced Medical PLC
9th Jul 20263:21 pmRNSForm 8.5 (EPT/RI) - Amend - Advanced Medical
9th Jul 20263:20 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
9th Jul 20263:18 pmEQSForm 8.3 - ADVANCED MEDICAL SOLUTIONS GROUP PLC
9th Jul 20262:30 pmRNSForm 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
9th Jul 20262:28 pmPRNInvesco Ltd: Form 8.3 - Advanced Medical Solutions Group Plc; Public dealing disclosure
9th Jul 20262:04 pmRNSForm 8.5 (EPT/RI) - Amend - Advanced Medical PLC
9th Jul 20262:00 pmGNWForm 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
9th Jul 20261:57 pmRNSForm 8.5 (EPT/RI) - Amend - Advanced Medical
9th Jul 202612:09 pmRNSForm 8.3 - Advanced Medical Solutions 08.07.2026
9th Jul 202612:06 pmRNSForm 8.5 (EPT/RI) - ADVANCED MEDICAL SOLUTIONS
9th Jul 202611:58 amRNSForm 8.5 (EPT/NON-RI) - ADVANCED MEDICAL GROUP PLC
9th Jul 202611:42 amGNWForm 8.3 Advanced Medical Solutions Group
9th Jul 202611:30 amRNSForm 8.3 Advanced Medical Solutions Group Plc
9th Jul 202610:55 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
9th Jul 20269:49 amRNSForm 8.5 (EPT/RI) - Advanced Medical Solutions Grp
9th Jul 20269:36 amGNWForm 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 08 07 2026] - (CGWL)
9th Jul 20267:00 amRNSForm 8.3 - Advanced Medical Solutions
8th Jul 20263:26 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
8th Jul 20263:20 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
8th Jul 20261:41 pmRNSForm 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
8th Jul 20261:33 pmGNWForm 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
8th Jul 202612:02 pmRNSForm 8.5 (EPT/RI) - ADVANCED MEDICAL SOLUTION
8th Jul 202611:57 amRNSForm 8.5 (EPT/NON-RI) - ADVANCED MEDICAL GROUP PLC
8th Jul 202611:32 amGNWForm 8.3 - Advanced Medical Solutions Group
8th Jul 202610:47 amRNSForm 8.3 Advanced Medical Solutions Group Plc
8th Jul 20269:21 amGNWForm 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 07 07 2026] - (CGWL)
7th Jul 20265:52 pmRNSForm 8.3 Advanced Medical Solutions plc
7th Jul 20263:45 pmRNSForm 8.5 (EPT/RI) - ADVANCED MEDICAL SOLUTIONS
7th Jul 20263:22 pmPRNInvesco Ltd: Form 8.3 - Advanced Medical Solutions Group PLC; Public dealing disclosure
7th Jul 20263:00 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
7th Jul 20263:00 pmRNSForm 8.3 - Advanced Medical Solutions Group PLC
7th Jul 20262:13 pmGNWForm 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
7th Jul 202612:58 pmGNWForm 8.3 Advanced Medical Solutions Group
7th Jul 202612:36 pmRNSForm 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
7th Jul 202612:06 pmRNSForm 8.3 AXA IM UK – Advanced Medical Solutions
7th Jul 202610:00 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
7th Jul 20269:41 amGNWForm 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 07 2026] - (CGWL)
7th Jul 20269:11 amRNSForm 8.5 (EPT/RI) - Advanced Medical Solutions Grp
7th Jul 20267:00 amRNSForm 8.3- Advanced Medical Solutions Group Plc
6th Jul 20263:50 pmRNSForm 8.3 Advanced Medical Solutions Group plc
6th Jul 20263:00 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
6th Jul 20262:41 pmGNWForm 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
6th Jul 20262:28 pmGNWForm 8.3 Advanced Medical Solutions Group
6th Jul 20262:20 pmRNSRule 2.9 Announcement
6th Jul 202612:46 pmRNSForm 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
6th Jul 202611:31 amRNSForm 8.5 (EPT/RI) - Advanced Medical Solution
3rd Jul 20263:55 pmRNSHolding(s) in Company
3rd Jul 20263:00 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
3rd Jul 20263:00 pmRNSForm 8.3 - Advanced Medical Solutions Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.